A Phase II Investigation of Oral Vinorelbine in Combination With Trastuzumab for 1st and 2nd Line Treatment of Women With Metastatic HER2 Positive Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 20 May 2015
At a glance
- Drugs Trastuzumab (Primary) ; Vinorelbine (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms OVINTRA
- 10 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Nov 2010 New trial record